Anderson Hoagland & Co’s Natus Medical Inc NTUS Stock Holding History

Anderson Hoagland & Co’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-27,358	Closed	-$1.07M	–	107
2017 Q1	$1.07M	Sell	27,358 -750	-3%	-$28.1K	0.58%	64
2016 Q4	$978K	Sell	28,108 -70	-0.2%	-$2.75K	0.57%	59
2016 Q3	$1.11M	Sell	28,178 -13,387	-32%	-$534K	0.64%	56
2016 Q2	$1.57M	Buy	+41,565	New	+$1.39M	0.97%	41

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DCM

Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return

Anderson Hoagland & Co's NTUS Position: Q2 2017 in Review

Anderson Hoagland & Co sold out of Natus Medical Inc (NTUS) in Q2 2017, closing a stake of 27,358 shares — an estimated $1.07M sold.

Anderson Hoagland & Co first reported a position in NTUS in Q2 2016 and held it in 4 quarters. The position peaked at $1.57M in Q2 2016. 217 funds tracked by Wall St. Rank hold NTUS as of Q2 2017.

Anderson Hoagland & Co reported no remaining Natus Medical Inc position as of Q2 2017 after selling out during the quarter.
Anderson Hoagland & Co sold 27,358 Natus Medical Inc shares in Q2 2017, an estimated $1.07M.
Anderson Hoagland & Co first reported a position in Natus Medical Inc in Q2 2016 and held it in 4 quarters.
Anderson Hoagland & Co's Natus Medical Inc position peaked at $1.57M in Q2 2016.
217 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2017.

Based on Anderson Hoagland & Co's 13F filing for Q2 2017, filed 19 Jul 2017.